The p110delta isoform of PI 3-kinase negatively controls RhoA and PTEN

Evangelia A Papakonstanti1, Anne J Ridley, Bart Vanhaesebroeck

  • 1Ludwig Institute for Cancer Research, London, UK.

The EMBO Journal
|June 22, 2007
PubMed

Insights

The PI3K/PTEN pathway, crucial for tumor suppression, is bidirectional. PI3K signaling reciprocally controls PTEN activity through the RhoA/ROCK pathway, revealing a novel feedback loop.

Area of Science:

  • Cellular Biology
  • Molecular Oncology
  • Signal Transduction

Background:

  • Phosphoinositide 3-kinase (PI3K) signaling is vital for tumor suppression, primarily through the action of PTEN.
  • The PTEN-PI3K interaction was considered unidirectional, with PTEN lipid degradation controlling cell functions.

Purpose of the Study:

  • To investigate the reciprocal regulation between PI3K and PTEN.
  • To elucidate the role of PI3K in controlling PTEN activity and cellular processes.

Main Methods:

  • Investigated the impact of p110delta PI3K inactivation in macrophages.
  • Analyzed signaling pathways involving RhoA, Akt, Rac1, and PTEN.
  • Utilized pharmacological inhibition of ROCK (a RhoA effector kinase).

Main Results:

  • Inactivation of p110delta PI3K led to increased RhoA and PTEN activity, despite reduced Akt and Rac1 activation.
  • Increased RhoA-GTP levels were linked to p190RhoGAP inactivation and reduced RhoA binding to p27.
  • ROCK inhibition reversed signaling defects, including Akt phosphorylation, chemotaxis, and proliferation.

Conclusions:

  • The PI3K/PTEN relationship is bidirectional, with PI3K negatively regulating PTEN via the RhoA/ROCK pathway.
  • Identifies the RhoA/ROCK pathway as a key mediator of p110delta PI3K signaling.
  • Establishes a novel feedback loop where PI3K controls itself through PTEN regulation.

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...